DMAC Competitors & Alternatives
Compare DiaMedica Therapeutics Inc with similar stocks in the same industry
Biotechnology
DMAC
Main Stock$7.49
Tradestie Score
60
Market Cap
$354.59M
Analyst Upside
+106.9%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
MRVI
Maravai LifeSciences Holdings, Inc. Class A Common Stock
|
$6.36
|
$454.29M | - | 58 | Compare |
|
RAPT
RAPT Therapeutics, Inc. Common Stock
|
$58.02
|
$450.49M | - | 53 | Compare |
|
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
|
$20.41
|
$448.32M | - | 60 | Compare |
|
ATXS
Astria Therapeutics, Inc. Common Stock
|
$12.58
|
$425.52M | - | 58 | Compare |
|
ALMS
Alumis Inc. Common Stock
|
$28.10
|
$422.50M | - | 61 | Compare |
|
DRUG
Bright Minds Biosciences Inc. Common Stock
|
$75.93
|
$410.79M | - | 57 | Compare |
|
FDMT
4D Molecular Therapeutics, Inc. Common Stock
|
$11.30
|
$407.71M | - | 56 | Compare |
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$13.86
|
$386.68M | - | 64 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.00
|
$382.04M | - | 53 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$12.18
|
$371.64M | - | 63 | Compare |
More DMAC Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2834)
234 stocks in this industry